| Winger, Joseph Giles |
Duke University
United States |
Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer |
1R01CA291768-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Winters-Stone, Kerri M |
Oregon Health & Science University
United States |
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
5R01CA248059-05 |
|
Goli Samimi, Ph.D., M.P.H. |
| Wolpin, Brian Matthew |
Dana-Farber Cancer Inst
United States |
Altered metabolism and machine learning for pancreatic cancer early detection |
5U01CA210171-08 |
|
Matthew Young, Ph.D. |
| Wong, David T |
University Of California Los Angeles
United States |
Characterizing longitudinal dynamics of indeterminate pulmonary nodules using semantic, radiomic, and deep features |
3U01CA233370-07S1 |
|
|
| Wright, Alexi A |
Dana-Farber Cancer Inst
United States |
Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors |
1R01CA289547-01 |
|
Goli Samimi, Ph.D., M.P.H. |
| Wu, Yun |
State University Of New York At Buffalo
United States |
Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection |
5R21CA267934-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Wu, Bechien |
Kaiser Foundation Research Institute
United States |
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT) |
5R01CA230442-05 |
|
Matthew Young, Ph.D. |
| Wu, Yun |
State University Of New York At Buffalo
United States |
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay |
5R01CA272827-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Xiao, Yi |
University Of Tx Md Anderson Can Ctr
United States |
Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1 |
1R21CA286318-01 |
|
Anda Vlad, M.D., Ph.D. |
| Xing, Chengguo |
University Of Florida
United States |
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation |
5R03CA273467-02 |
|
Gabriela Riscuta, M.D., CNS |